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Some of cyclo (Nα-di-nicotinoyl)[L-phenylalanyl-L-leucine]pentapeptides3-6 has been synthesized starting from bis- 
(1-carboxy-2-substituted)-3,5-diaminocarbonyl)pyridine 3 and N,N-bis-(1-hydrazonyl-2-substituted)-3,5 diaminocarbonyl) 
pyridine 2. Treatment of 1 or 2 afforded the corresponding bis-ester derivative 3, which was hydrolyzed with sodium 
hydroxideto give bis-acid 4. Cyclization of bis-acid 4 with L-dibasic amino acid methyl esters, afforded the corresponding 
macrocyclic methyl esters 5a,b, respectively. Finally, hydrazonolysis of 5a,b with hydrazine hydrated in refluxing methanol 
afforded macrocyclic pentapeptide hydrazides 6a,b, respectively. Some of these compounds exhibited antimicrobial 
activities comparable with Chloramphenicol and Fusidic acid as reference drugs. 
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Introduction 
Nicotinic acid and nicotinamide are similar in their 
vitamin activity. However, some of the new 
heterocyclic and peptide derivatives have been studied 
with respect to antiviral
1
, anti-inflammatory
2
, 
enzymatic peptide
3
, antimicrobial activities
4,5
 and there 
used as an antimicrobial for therapeutic applications
6
. 
On the other hand, some of reported macrocyclic 
peptides derivatives were synthesized from 
pyridinedicarboxylic acids with selected amino acids 
and evaluated of their biological and pharmacological 
activities
7-10
. The small molecules of peptide 
derivatives have been anticancer activity and effective 
against cancerous cells by either membranolytic 
mechanism or disruption of mitochondria
11-13
. Also, the 
synthesis of macrocyclic and complexing properties of 
azacrown compounds has been a subject of intensive 
exploration and existing antibacterial agents
14-18
. In 
view of these observations and as continuation of our 
previous works
7-10
 in macrocyclic and heterocyclic 
chemistry, we have synthesized some new cyclo (Nα-
di-nicotinoyl)[L-phenylalanyl-L-leucine]pentapeptides 
and they are tested as antimicrobial agents.  
 
Materials and methods 
Chemistry 
Melting points were determined in open glass 
capillary tubes with an Electro Thermal Digital melting 
point apparatus (model: IA9100) and are uncorrected. 
Elemental microanalysis for carbon, hydrogen and 
nitrogen (Microanalytical Unit, NRC) was found 
within the acceptable limits of the calculated values. IR 
(KBr) was recorded on a Nexus 670 FTIR Nicolet, 
Fourier Transform infrared spectrometer. Proton and 
carbon nuclear magnetic resonance (
1
H- and 
13
C NMR) 
spectra were run in (DMSO-d6) on Jeol 500 MHz 
instruments. Mass spectra were run on a MAT 
Finnigan SSQ 7000 spectrometer (Shimadzu, Kyoto, 
Japan; Model: QP2010 ultra), using the electron impact 
technique (EI).  
 
Synthesis of dimethyl 2,2'-((2,2'-((pyridine-3, 
5-dicarbonyl) bis(azanediyl))bis(3-phenyl-
propanoyl))bis(azanediyl))bis(4-methylpentanoate) (3). 
Mixed anhydride[A]: To a mixture of diacid1 (1 mmol) 
—————— 
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and ethyl chloroformate (22g, 2 mmol) in 
dichloromethane (25 mL) at -20
o
C, triethylamine  
(0.2g, 2 mmol) was added, and stirred for 20 min., and 
then L-leucine methyl ester (2 mmol) was added at the 
same temperature. The reaction mixture was stirred at  
(-20
o
C) for 6 hrs and then overnight at room 
temperature. The obtained mixture was washed with 
H2O, 1N HCl, 1N Na2CO3 and water then dried over 
anhydrous calcium chloride. The solvent was 
evaporated, and the crude product was purified by 
crystallization from ethanol/n-hexane to give the ester 
derivative3 in 86% yield. 
Azid method [B]:A mixture of the dihydrazide2  
(1 mmol) in 5 N HCl (1.2 mL) with glacial acetic acid 
(2.4 mL) and water (10 mL) was stirred for 10 min at 
-5 ◦C, then NaNO2 (0.138 g, 2 mmol in 6 mL of 
water) was added and the mixture was stirred for  
30 min. The obtained azide was extracted with 
dichloromethane (120 mL), washed with cold water, 
3% aqueous sodium bicarbonate followed by cold 
water, and dried over anhydrous calcium chloride. 
The obtained azide solution was added in one portion 
to a cold solution (-5 ◦C) of the L-lucine methyl  
ester (2 mmol) in dry dichloromethane (25 mL). The 
reaction mixture was stirred at the same temperature 
for 3 h, then overnight at r.t., washed with 1 N 
hydrochloric acid, 1N aqueous sodium bicarbonate, 
water and dried over anhydrous calcium chloride. The 
solvent was distilled off to give the corresponding 
3,5-bis-ester derivative 3 in 65% yield, as identified 
by melting point and TLC in comparison with 
authentic sample prepared according to method A. 
m.p. 190-192 °C. []
25
D
 = - 95 (c = 0.5, MeOH). IR 
(film): ν = 3385 (NH), 1749 (C=O, ester), 1655, 1536, 
1254 (3C=O, amides) cm
-1
. 
1H NMR: δ = 0.85-1.02 
(m, 12H, 4CH3), 1.62-1.68 (m, 4H, 2CH2), 2.35-2.39 
(m, 2H, 2CH), 3.44 (d, 4H, 2CH2), 3.69 (s, 6H, 
2OCH3), 4.12-4.25 (m, 2H, 2CH), 4.56-4.60 (m, 2H, 
2CH), 6.98-7.46 (m, 10H, 2Ph-H), 8.40, 9.10 (2s, 3H, 
pyr-H) and 8.70, 8.88 (2s, 4H, 4NH, exchangeable 
with D2O). 
113C NMR: δ = 20.32, 20.48, 22.98, 38.14, 
40.62, 50.66, 52.75, 54.36, 125.25, 127.86, 129.00, 
138.78, 132.00, 139.88, 152.04, 165.48, 168.76, 
172.45 (39C).MS (EI, 70 eV): m/z (%) = 715 (95) 
[M
+
]. C39H49N5O8 (715.84): Calcd: C 65.44, H 6.90, 
N 9.78; found: C 65.35, H 6.76, N 9.72.  
Synthesis of 2,2'-((2,2'-((pyridine-3,5-dicarbonyl) 
bis(azanediyl))bis(3-phenylpropanoyl))bis-(azanediyl)) 
bis (4-methylpentanoic acid) (4). Sodium hydroxide  
(1N, 25 mL) was added to cold methanolic solution of 
the tetrapeptide ester (3) (1 mmol) with stirring at  
-5 
o
C. The reaction mixture was stirred for 2 h at the 
same temperature then for 3 h at room temperature. 
The solvent was distilled off, the aqueous solution 
was cooled and acidified with 1 N hydrochloric acid 
to pH ~ 3. The obtained solid was filtered off, washed 
with water, dried and crystallized from ethanol/water 
to give to give 3,5-bis acid derivative 4. In 94% yield; 
m.p. 246-248 °C.[]
25
D
 = - 105(c = 0.5, MeOH). IR 
(film): ν = 4568-3384 (OH, NH), 1723 (C=O, acid), 
1658, 1535, 1255 (3C=O, amides) cm
-1
. 
1
H NMR:  
δ = 0.90-0.96 (m, 12H, 4CH3), 1.66-1.72 (m, 4H, 
2CH2), 2.16-2.34 (m, 2H, 2CH), 3.48 (d, 4H, 2CH2), 
4.28-4.32 (m, 2H, 2CH), 4.35-4.45 (m, 2H, 2CH), 
7.08-7.46 (m, 10H, 2Ph-H), 8.51, 9.04 (m, 3H,  
pyr-H), 8.74, 8.90 (2s, 4H, 4NH, exchangeable with 
D2O), 11.55 (s, 2H, 2OH, exchangeable with D2O). 
13C NMR: δ = 21.05, 20.48, 22.88, 37.98, 40.50, 
50.60, 52.70, 125.36, 127.84, 129.08, 138.86, 131.95, 
139.92, 152.15, 166.50, 169.74, 174.32 (37C).MS  
(EI, 70 eV): m/z (%) = 688 (76) [M
+
]. C37H45N5O8 
(687.78): Calcd: C 64.61, H 6.59, N 10.18; found:  
C 64.45, H 6.52, N 10.14.  
Synthesis of 3,5-pyridine-cyclic [L-phenylalanyl-L-
leucine]pentapeptide methyl esters (5a,b). The same 
procedure which was used in synthesized compound 
3, by using compound 2 instead of compound 1.  
Methyl 4,19-dibenzyl-7,16-diisobutyl-2,5,8,15,18,21- 
hexaoxo-3,6,9,14,17,20-hexaaza-1(3,5)-pyridinacyclo- 
henicosaphane-10-carboxylate (5a). Yield 72%; m.p. 
202-204 °C. []
25
D
 = - 112 (c = 0.5, MeOH). IR 
(film): ν = 3388 (NH), 1752 (C=O, ester), 1655, 1538, 
1254 (3C=O, amides) cm
-1
. 
1H NMR: δ = 0.86-0.92 
(m, 12H, 4CH3), 1.25-1.46 (m, 4H, 2CH2), 1.58-1.76 
(m, 4H, 2 CH2), 2.18-2.34 (m, 2H, 2CH), 3.02-3.22 
(m, 2H, CH2), 3.34 (d, 4H, 2CH2), 3.53 (s, 3H, 
OCH3), 3.86-4.08 (m, 4H, 4CH), 4.36-4.46 (m, 1H, 
CH), 7.10-7.34 (m, 10H, 2Ph-H),8.45, 9.00 (2s, 3H, 
pyr-H), 8.84, 8.96, 9.20 (3s, 6H, 6NH, exchangeable 
with D2O). 
13C NMR: δ = 20.85, 21.24, 23.05, 28.56, 
30.48, 37.95, 37.80, 41.10, 50.98, 52.69, 53.66, 60.50, 
125.42, 127.54, 128.00, 139.12, 132.10, 140.05, 
152.10, 166.74, 170.14, 172.85 (43C).MS (EI,  
70 eV): m/z (%) = 798 (58) [M
+
]. C43H55N7O8 
(797.94): Calcd: C 64.72, H 6.95, N 12.29; Found: C 
64.58, H 6.80, N 12.22.  
Methyl 4,20-dibenzyl-7,17-diisobutyl-2,5,8,16,19,22- 
hexaoxo-3,6,9,15,18,21-hexaaza-1(3,5)-pyridinacyclo-
docosaphane-10-carboxylate (5b). Yield 65%; m.p. 
190-192 °C. []
25
D
 = - 98 (c = 0.5, MeOH). IR (film): 
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ν = 3362 (NH), 1746 (C=O, ester), 1656, 1534, 1252 
(3C=O, amides) cm
-1
. 
1H NMR: δ = 0.88-0.94 (m, 
12H, 4CH3), 1.23-1.46 (m, 4H, 2CH2), 1.60-1.75 (m, 
4H, 2 CH2), 2.28-2.35 (m, 2H, 2CH), 3.00-3.26 (m, 
4H, 2 CH2), 3.38 (d, 4H, 2CH2), 3.56 (s, 3H, OCH3), 
3.96-4.04 (m, 4H, 4CH), 4.40-4.45 (m, 1H, CH), 
7.10-7.48 (m, 10H, 2Ph-H), 8.45, 9.00 (2s, 3H, pyr-
H), 8.86, 8.96, 9.20 (3s, 6H, 6NH, exchangeable with 
D2O). 
13C NMR: δ = 20.75, 21.18, 23.02, 22.60, 
28.72, 30.52, 43.90, 37.92, 41.15, 51.02, 52.74, 53.70, 
60.52, 125.40, 127.50, 128.04, 139.16, 132.12, 
140.00, 152.14, 167.00, 170.02, 173.12 (44C). MS 
(EI, 70 eV): m/z (%) = 812 (62) [M
+
]. C44H57N7O8 
(811.97): Calcd: C 65.09, H 7.08, N 12.08; Found:  
C 64.97, H 7.01, N 11.98.  
Synthesis of 3,5-pyridine cyclic [L-phenylalanyl-L-
leucine]pentapeptide hydrazides (6a,b). A mixture of 
pentapeptide esters5a,b(1 mmol) and hydrazine 
hydrate (0.2 mL, 4 mmol) in absolute methanol  
(25 mL) was refluxed for 6 h. The solvent was 
evaporated to dryness, the obtained residue was 
washed with n-hexane. The obtained solid was 
crystallized from methanol to give cyclic [L-
phenylalanyl-L-leucine]pentapeptide hydrazides6a,b, 
respectively. 
4,19-Dibenzyl-7,16-diisobutyl-2,5,8,15,18,21-
hexaoxo-3,6,9,14,17,20-hexaaza-1(3,5)-pyridinacyclo 
henicosaphane-10-carbohydrazide (6a). Yield 72%; 
m.p. 248-250 °C. []
25
D
 = - 102 (c = 0.5, MeOH). IR 
(film): ν = 3390-3370 (NH, NH2), 1654, 1536, 1255 
(3C=O, amides) cm
-1
. 
1H NMR: δ = 0.84-0.92  
(m, 12H, 4CH3), 1.24-1.45 (m, 4H, 2CH2), 1.62-1.74 
(m, 4H, 2 CH2), 2.26-2.34 (m, 2H, 2CH), 3.10-3.18 
(m, 2H, CH2), 3.35 (d, 4H, 2CH2), 3.86-4.00 (m, 4H, 
4CH), 4.23 (s, 2H, NH2), 4.38-4.45 (m, 1H, CH), 
7.10-7.34 (m, 10H, 2Ph-H),8.40, 9.08 (2s, 3H, pyr-H), 
9.10 (s, 1H, CONH, D2O exchangeable), 8.82, 8.95, 
9.18 (3s, 6H, 6NH, exchangeable with D2O).  
13C NMR: δ = 20.68, 21.42, 23.22, 25.56, 28.48, 
32.84, 37.62, 40.65, 50.70, 52.85, 54.90, 125.70, 
126.96, 128.08, 139.00, 131.87, 139.65, 151.90, 
169.78, 170.75, 170.12 (42C). MS (EI, 70 eV): m/z (%) 
= 798 (65) [M
+
]. C42H55N9O7 (797.94): Calcd: C, 63.22; 
H, 6.95; N, 15.80; Found: C, 63.00, H, 6.85, N, 15.72.  
4,20-Dibenzyl-7,17-diisobutyl-2,5,8,16,19,22-
hexaoxo-3,6,9,15,18,21-hexaaza-1(3,5)-pyridinacyclo 
docosaphane-10-carbohydrazide (6b). Yield 65%; 
m.p. 265-267 °C. []
25
D
 = - 115 (c = 0.5, MeOH). IR 
(film): ν = 3420-3394 (NH, NH2), 1650, 1534, 1252 
(3C=O, amides) cm
-1
. 
1H NMR: δ = 0.86-0.92 (m, 
12H, 4CH3), 1.25-1.46 (m, 4H, 2CH2),  
1.58-1.74 (m, 4H, 2 CH2), 2.28-2.36 (m, 2H, 2CH), 
3.00-3.24 (m, 4H, 2CH2), 3.35 (d, 4H, 2CH2),  
3.90-4.05 (m, 4H, 4CH), 4.30 (s, 2H, NH2), 4.36-4.46  
(m, 1H, CH), 7.15-7.32 (m, 10H, 2Ph-H),8.45, 9.00 
(2s, 3H, pyr-H), 9.10 (s, 1H, CONH, D2O 
exchangeable, Hydrazide), 8.85, 8.95, 9.18 (3s, 6H, 
6NH, exchangeable with D2O). 
13C NMR: δ = 20.55, 
21.65, 22.99, 22.15, 28.55, 31.95, 44.65, 37.60, 40.82, 
52.15, 53.45, 56.84, 125.36, 126.72, 128.12, 139.05, 
131.84, 139.68, 151.92, 169.66, 170.58, 170.05 
(43C). MS (EI, 70 eV): m/z (%) = 812 (55) [M
+
]. 
C43H57N9O7 (811.97): Calcd: C 63.61; H 7.08;  
N 15.53; Found: C 63.55, H 6.95, N 15.45.  
 
Antimicrobial evaluation  
The experimental method which was used in the 
antimicrobial evaluation has been adopted from 
Nehad et al
19
. 
 
Result and Discussion 
Chemistry 
In the present work, a series of several linear 
tetrapeptide and macrocyclic pentapeptide derivatives 
were synthesized based on compounds 1 and 2 which 
was synthesized from 3,5-pyridinedicarbonyl chloride, 
according to the previous reported procedures
1,20,21
 
(Figure 1). The synthesis of N
α
-dinicotenoyl-bis 
[L-phenylalanyl-L-leucine]methyl ester] derivative (3) 
was based on the acid 1 and the hydrazide 2. Treatment 
of L-phenylalanine methyl ester hydrochloride with 
dipeptide acid 3 (Mixed anhydride method) or 
dipeptide acid hydrazide 2 (Azide method) afforded  
the corresponding N
α
-dinicotinoyl-bis[L-phenylalanyl-
L-leucine]methyl ester] derivative (3). The hydrolysis 
of bis-ester 3 with sodium hydroxide (2% methanolic 
solution) afforded the N
α
-dinicotinoyl-bis[L-
 
 
Fig.1 — Chemical structure for starting materials 1 and 2 
J SCI IND RES VOL 79 JANUARY 2020 
 
 
74 
phenylalanyl-L-leucine] acid] derivative (4). 
Cyclization of tetrapeptidebis-acid (4) with L-dibasic 
amino acid methyl esters, namely, L-ornithine methyl 
ester or L-lysine methyl ester afforded the 
corresponding cyclo (N
α
-di-nicotinoyl)[L-phenylalanyl- 
L-leucine] pentapeptide methyl esters5a and 5b, 
respectively. Finally, hydrazonolysis of the last 
compounds 5a,b by treating with hydrazine hydrated in 
refluxing methanol afforded macrocyclic pentapeptide 
hydrazides 6a,b, respectively (Scheme 1).  
 
Antimicrobial activity 
The newly synthesized compounds 2-6 were tested 
for their preliminary antimicrobial activity against the 
 
 
Scheme 1 — Synthetic routes for compounds 3-6 
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following microorganisms: Escherichia coli (E. coli), 
Pseudomonas putide (P. putide), Bacillus subtilis  
(B. subtilis), Streptococcuslactis (Staph. Lactis), 
Aspergillus niger (A. niger), Penicillium sp. and 
Candida albicans (C. albican). From the results in 
Table 1 showed that all synthesized compounds 
exhibited both antibacterial and antifungal activities 
on all tested microbial strains, except for compounds 
2, 3, and 4, which did not showed activity against 
Candida albicans.  
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